A framework for establishing scientific confidence in new approach methodologies

AJ Van Der Zalm, J Barroso, P Browne, W Casey… - Archives of …, 2022 - Springer
Robust and efficient processes are needed to establish scientific confidence in new
approach methodologies (NAMs) if they are to be considered for regulatory applications …

[HTML][HTML] Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet

A Bender, I Cortés-Ciriano - Drug discovery today, 2021 - Elsevier
Highlights•Artificial Intelligence (AI) has transformed many areas such as speech and image
recognition, but not yet drug discovery.•Approaches to AI in drug discovery need to take in …

Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations

KR McSweeney, LK Gadanec, T Qaradakhi, BA Ali… - Cancers, 2021 - mdpi.com
Simple Summary Nephrotoxicity is the dose-limiting factor of cisplatin treatment.
Nephrotoxicity is characterized by reduced kidney function. Although an often-reversible …

[HTML][HTML] Reliability of common mouse behavioural tests of anxiety: A systematic review and meta-analysis on the effects of anxiolytics

M Rosso, R Wirz, AV Loretan, NA Sutter… - Neuroscience & …, 2022 - Elsevier
The validity of widely used rodent behavioural tests of anxiety has been questioned, as they
often fail to produce consistent results across independent replicate studies. In this study, we …

Synthesis and functionalization of graphene materials for biomedical applications: recent advances, challenges, and perspectives

Y Xiao, YX Pang, Y Yan, P Qian, H Zhao… - Advanced …, 2023 - Wiley Online Library
Since its discovery in 2004, graphene is increasingly applied in various fields owing to its
unique properties. Graphene application in the biomedical domain is promising and …

The sheep as a large animal model for the investigation and treatment of human disorders

A Banstola, JNJ Reynolds - Biology, 2022 - mdpi.com
Simple Summary We review the value of large animal models for improving the translation of
biomedical research for human application, focusing primarily on sheep. Abstract An …

First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia B

P Harmatz, CE Prada, BK Burton, H Lau, CM Kessler… - Molecular Therapy, 2022 - cell.com
Zinc-finger nuclease (ZFN)-based in vivo genome editing is a novel treatment that can
potentially provide lifelong protein replacement with single intravenous administration …

Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina

T Driedonks, L Jiang, B Carlson, Z Han… - Journal of …, 2022 - Wiley Online Library
Extracellular vesicles (EVs) have potential in disease treatment since they can be loaded
with therapeutic molecules and engineered for retention by specific tissues. However …

Lipocalin 2 receptors: facts, fictions, and myths

SK Schröder, N Gasterich, S Weiskirchen… - Frontiers in …, 2023 - frontiersin.org
The human 25-kDa Lipocalin 2 (LCN2) was first identified and purified as a protein that in
part is associated with gelatinase from neutrophils. This protein shows a high degree of …

Extracellular vesicles from mesenchymal stem cells: towards novel therapeutic strategies for neurodegenerative diseases

E Turano, I Scambi, F Virla, B Bonetti… - International Journal of …, 2023 - mdpi.com
Neurodegenerative diseases are fatal disorders of the central nervous system (CNS) which
currently lack effective treatments. The application of mesenchymal stem cells (MSCs) …